TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction.

The activity of TIMP-3, a natural tissue inhibitor of matrix metalloproteinases (MMPs), is decreased in the failing heart. This study evaluated the response to coronary ligation of cardiac structure, function, and matrix remodeling in wild-type (WT) mice, and those deficient in TIMP-3 (timp-3(-/-)). The coronary artery was ligated in timp-3(-/-) and age-matched WT mice. At various time points over the following 28-day period, left ventricular structure and function (by echocardiography, pressure-volume measurements and morphometry), MMP levels and activity, blood vessel density, cell proliferation, apoptosis, matrix structure, and inflammatory cytokine levels were assessed in both groups. After ligation, mortality was significantly greater in timp-3(-/-) than in WT mice. Morphometry and echocardiography demonstrated no difference in heart size or function prior to ligation; however, the progression of left ventricular systolic dysfunction was accelerated in timp-3(-/-) mice at 7, 14 and 28 days after infarction compared to WT controls. Left ventricular dilatation, gelatinase MMP activity, and TNF-alpha levels were significantly greater in timp-3(-/-) than in WT mice at different times after ligation. By histological evaluation, timp-3(-/-) mice exhibited significantly increased blood vessel density, cell proliferation, and apoptosis in the infarct area, and reduced collagen content in the viable remote myocardium compared to WT mice at 7 and 14 days after ligation. TIMP-3 deficiency accelerated maladaptive cardiac remodeling after a myocardial infarction by promoting matrix degradation and inflammatory cytokine expression. This study supports further investigations to determine whether such remodeling could be reduced by augmenting TIMP-3 expression in the infarcted myocardium.

[1]  R. Schulz,et al.  Imbalance Between Tissue Inhibitor of Metalloproteinase-4 and Matrix Metalloproteinases During Acute Myoctardial Ischemia-Reperfusion Injury , 2003 .

[2]  Y. Sun,et al.  Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. , 1998, Circulation.

[3]  R. Khokha,et al.  Lack of tissue inhibitor of metalloproteinases-3 results in an enhanced inflammatory response in antigen-induced arthritis. , 2005, The American journal of pathology.

[4]  P. Libby,et al.  Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. , 2000, The Journal of clinical investigation.

[5]  B. Strauss,et al.  Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation. , 2003, The Journal of thoracic and cardiovascular surgery.

[6]  Richard T. Lee,et al.  Selective Matrix Metalloproteinase Inhibition Reduces Left Ventricular Remodeling but Does Not Inhibit Angiogenesis After Myocardial Infarction , 2002, Circulation.

[7]  R. Visse,et al.  Matrix Metalloproteinases Regulation and Dysregulation in the Failing Heart , 2002 .

[8]  B. Fingleton,et al.  Abnormal TNF activity in Timp3−/− mice leads to chronic hepatic inflammation and failure of liver regeneration , 2004, Nature Genetics.

[9]  M. Zile,et al.  Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition. , 2005, American journal of physiology. Heart and circulatory physiology.

[10]  J. S. Janicki,et al.  Inadequate collagen tethers in dilated cardiopathy. , 1988, American heart journal.

[11]  W. Frederiks,et al.  In Situ Localization of Gelatinolytic Activity in the Extracellular Matrix of Metastases of Colon Cancer in Rat Liver Using Quenched Fluorogenic DQ-gelatin , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[12]  B. McGowan,et al.  Tumor Necrosis Factor Receptors 1 and 2 Differentially Regulate Survival, Cardiac Dysfunction, and Remodeling in Transgenic Mice With Tumor Necrosis Factor-&agr;–Induced Cardiomyopathy , 2004 .

[13]  R. Khokha,et al.  TIMP-3 Deficiency Leads to Dilated Cardiomyopathy , 2004, Circulation.

[14]  B. Strauss,et al.  Matrix remodeling in experimental and human heart failure: a possible regulatory role for TIMP-3. , 2003, American journal of physiology. Heart and circulatory physiology.

[15]  E. Creemers,et al.  Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice. , 2003, American journal of physiology. Heart and circulatory physiology.

[16]  S. Fazel,et al.  Cell transplantation preserves cardiac function after infarction by infarct stabilization: augmentation by stem cell factor. , 2005, The Journal of thoracic and cardiovascular surgery.

[17]  M. Satoh,et al.  Tumor Necrosis Factor-α–Converting Enzyme and Tumor Necrosis Factor-α in Human Dilated Cardiomyopathy , 1999 .

[18]  A. Baker,et al.  Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. , 1998, The Journal of clinical investigation.

[19]  R. Khokha,et al.  Combination of Tumor Necrosis Factor-α Ablation and Matrix Metalloproteinase Inhibition Prevents Heart Failure After Pressure Overload in Tissue Inhibitor of Metalloproteinase-3 Knock-Out Mice , 2005, Circulation research.

[20]  N. Doll,et al.  Regression of Left Ventricular Hypertrophy After Surgical Therapy for Aortic Stenosis Is Associated With Changes in Extracellular Matrix Gene Expression , 2001, Circulation.

[21]  R. Visse,et al.  This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .

[22]  C. Murry,et al.  Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. , 2003, The American journal of pathology.

[23]  L. Claesson‐Welsh,et al.  A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 , 2003, Nature Medicine.

[24]  B. Bozkurt,et al.  Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective. , 2002, Cardiovascular research.

[25]  F. Gao,et al.  Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts. , 2005, American journal of physiology. Heart and circulatory physiology.

[26]  T. Mak,et al.  Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). , 2001, The Journal of clinical investigation.

[27]  J. H. Dierendonck,et al.  A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[28]  J. Weitzman,et al.  Examining the relationship between the gelatinolytic balance and the invasive capacity of endothelial cells. , 1999, Journal of cell science.

[29]  M. Zile,et al.  Changes in extracellular collagen matrix alter myocardial systolic performance. , 2003, American journal of physiology. Heart and circulatory physiology.